Frank Mottola - Aug 25, 2025 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: SVP, Quality, GMP, Ops, IT
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Stock symbol: SUPN
Transactions as of: Aug 25, 2025
Transactions value $: -$441,420
Form type: 4
Date filed: 8/27/2025, 04:59 PM
Previous filing: Mar 7, 2025
Next filing: Sep 15, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Mottola Frank	SVP, Quality, GMP, Ops, IT	C/O SUPERNUS PHARMACEUTICALS, INC.,, 9715 KEY WEST AVENUE, ROCKVILLE	/s/ Timothy C. Dec, as attorney-in-fact	2025-08-27	0001804567

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SUPN	Common Stock	Options Exercise	$182K	+14K	+90.35%	$12.98	29.5K	Aug 25, 2025	Direct	F1
transaction	SUPN	Common Stock	Sale	-$623K	-14K	-47.46%	$44.51	15.5K	Aug 25, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Employee Stock Option (Right to Buy)	Options Exercise	$0	-14K	-100%	$0.00	0	Aug 25, 2025	Common Stock	14K	$12.98	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
F2	The Reporting Person exercised the options indicated herein and sold the underlying shares prior to the expiration of such options on March 1, 2026.
F3	The option vests in four equal annual installments beginning on March 1, 2017.